compar
efficaci
recombin
felin
interferon
omega
refractori
case
calicivirusposit
cat
caudal
stomat
randomis
multicentr
control
doubleblind
studi
cat
chronic
caudal
stomat
alveolarbucc
mucos
calicivirusposit
cat
sever
present
felin
chronic
gingivostomat
refractori
case
help
antibiot
antiinflammatori
treatment
often
includ
glucocorticoid
order
evalu
compar
efficaci
oromucos
administr
recombin
felin
interferon
omega
rfeifnu
versu
oral
administr
glucocorticoid
randomis
multicentr
control
doubleblind
studi
perform
cat
progress
behaviour
clinic
lesion
score
assess
day
daili
oromucos
treatment
mu
rfeifnu
associ
signific
improv
clinic
lesion
caudal
stomat
alveolarbucc
mucos
decreas
pain
score
although
statist
improv
notic
prednisolon
group
howev
signific
differ
two
group
paramet
except
pain
f
elin
chronic
gingivostomat
fcg
illdefin
syndrom
characteris
inflammatori
lesion
mostli
ulcer
ulceroprolif
natur
affect
gingiv
nongingiv
oral
mucosa
apart
inflamm
associ
periodont
diseas
recognis
high
preval
cat
inflammatori
lesion
identifi
cat
two
specif
unusu
anatom
site
mucosa
later
palatogloss
arch
alveolar
mucosa
premolarmolar
area
sometim
extend
buccal
mucosa
inflammatori
condit
recent
respect
reterm
caudal
stomat
alveolarbucc
mucos
main
featur
cat
treat
pain
condit
fcg
syndrom
may
relat
variou
oral
inflammatori
lesion
among
gingivitisperiodont
predomin
broad
term
use
caution
alway
specifi
whether
fcg
associ
caudal
stomat
signific
factor
seem
presenc
absenc
type
lesion
thought
clinic
entiti
multifactori
condit
host
immun
system
respond
inappropri
chronic
oral
antigen
stimul
variou
origin
dental
relat
condit
periodont
diseas
dental
resorpt
well
influenc
viral
infect
carriag
suggest
play
role
caliciviru
known
long
time
caus
acut
focal
multifoc
ulcer
glossiti
palat
well
acut
upper
respiratori
disord
preval
caliciviru
carriag
associ
chronic
gingivitisstomat
also
report
higher
random
popul
specif
shown
acut
caudal
stomat
experiment
induc
caliciviru
strain
sampl
oropharynx
cat
suffer
chronic
stomat
howev
experiment
induc
acut
caudal
stomat
result
chronic
diseas
experiment
set
recent
shown
use
polymeras
chain
reaction
pcr
technolog
almost
cat
present
caudal
stomat
chronic
oral
caliciviru
carrier
wherea
cat
chronic
gingivitisstomat
without
caudal
stomat
specif
felin
caliciviru
fcv
biotyp
respons
stomat
observ
howev
chronic
carrier
state
cat
shown
relat
emerg
antigen
distant
virus
suggest
antigen
variat
result
seri
mutat
induc
immunolog
pressur
chronic
infect
constitut
escap
mechan
viru
medic
treatment
gingivostomat
cat
caudal
stomat
unreward
specif
treatment
show
superior
extract
teeth
vicin
alveolar
mucos
caudal
stomat
well
teeth
suffer
periodont
resorpt
lesion
order
suppress
chronic
oral
antigen
stimul
shown
best
result
cat
clinic
cure
significantli
improv
cat
show
littl
improv
refractori
case
requir
constant
medic
therapi
antibiot
antiinflammatori
drug
corticosteroid
often
use
clinician
order
decreas
oral
inflamm
stimul
appetit
interferon
ifn
famili
cytokin
first
recognis
abil
imped
viral
replic
function
inde
critic
host
surviv
respons
viral
infect
bind
specif
receptor
cell
surfac
induc
signal
synthesi
certain
number
enzym
protein
kinas
oligoadenyl
synthetas
mx
protein
gtpase
interfer
cellular
viral
process
ifn
directli
protect
cell
viral
infect
rather
render
cell
less
suitabl
environ
viral
replic
two
differ
type
ifn
distinct
immunolog
properti
type
ifn
includ
number
ifna
subtyp
produc
almost
cell
appropri
condit
ifnu
also
type
ifn
describ
recombin
felin
interferon
omega
rfeifnu
market
parvoviru
infect
dog
retrovirus
cat
shown
share
typic
characterist
type
human
ifn
antivir
activ
felin
herpesviru
fcv
felin
coronaviru
recent
studi
shown
antivir
activ
rfeifnu
variou
virus
higher
feifna
human
ifna
use
cat
parenter
administr
iv
im
sc
result
product
neutralis
antibodi
inhibit
therapeut
effect
activ
principl
administr
speciesspecif
felin
ifn
rfeifn
shown
prevent
event
mucos
administr
ifn
also
investig
therapeut
effect
ifn
oromucos
administr
due
immunomodulari
activ
oropharyng
lymphoid
tissu
via
paracrin
activ
glycoprotein
destroy
transit
digest
tract
biolog
activ
ifn
mucos
applic
detect
cat
dosedepend
fashion
evalu
mx
protein
express
white
blood
cell
base
data
rfeifnu
tri
field
topic
ophthalmolog
medic
case
herpet
conjunct
kerat
well
local
therapi
local
infiltr
oromucos
administr
fcg
syndrom
use
rfeifnu
oromucos
administr
fcg
substanti
publish
studi
although
singl
publish
case
report
purpos
studi
compar
efficaci
glucocorticoid
treatment
versu
oromucos
administr
rfeifnu
calicivirusposit
cat
suffer
chronic
caudal
stomatitisalveolar
mucos
refractori
dental
extract
treatment
fortythre
cat
fcg
recruit
clinic
popul
present
veterinari
practic
specialis
dentistri
locat
five
european
countri
belgium
franc
germani
spain
switzerland
fig
among
includ
case
four
lost
followup
immedi
inclus
day
withdrawn
statist
analysi
protocol
deviat
amongst
remain
cat
variou
breed
repres
british
shorthair
one
domest
shorthair
dsh
five
european
main
coon
three
persian
one
siames
two
cross
breed
one
anim
characterist
baselin
summaris
tabl
includ
anim
calicivirusposit
cat
present
refractori
gingivostomat
defin
inclus
criteria
summaris
tabl
sampl
clinic
case
submit
analysi
depart
scane
laboratori
franc
detect
fcv
rna
realtim
revers
transcriptasepcr
rtpcr
realtim
rtpcr
design
conserv
region
viral
genom
use
detect
fcv
rna
describ
previous
cat
present
periodont
lesion
andor
alveolarbucc
mucos
without
caudal
stomat
receiv
immunomodulatori
therapi
cyclosporin
cytokinebas
protocol
ifn
within
previou
week
receiv
longact
glucocorticoid
progestagen
therapi
within
previou
week
suffer
diabet
mellitu
hyperadrenocortic
hepat
failur
chronic
renal
failur
enrol
studi
exclus
studi
appli
anim
whose
condit
need
administr
anoth
medic
treatment
case
unsatisfactori
result
cours
studi
anim
consid
case
treatment
failur
anim
develop
sever
unrel
diseas
anim
present
signific
sign
intoler
product
anim
receiv
whole
treatment
anim
receiv
forbidden
treatment
corticosteroid
test
studi
nonsteroid
antiinflammatori
drug
nsaid
authoris
frame
studi
product
progesteron
activ
immunomodul
immunosuppress
product
orodent
treatment
cours
studi
scale
clean
polish
select
extract
day
inclus
cat
alloc
random
one
randomis
plan
per
site
two
group
site
provid
vial
powder
diluent
well
tablet
either
identifi
product
rfeifnu
powderdilu
placebo
tablet
b
placebo
powderdilu
prednisolon
tablet
four
ident
envelop
mark
contain
label
letter
b
correspond
vial
tablet
use
studi
site
randomis
balanc
group
four
cat
two
cat
treat
product
two
cat
tabl
inclus
criteria
cat
includ
trial
meet
three
condit
present
lesion
fcg
characteris
specif
inflammatori
lesion
fcg
complex
bilater
caudal
stomat
alveolarbucc
mucos
caudal
stomat
intens
score
least
equal
score
area
caudal
stomat
lesion
least
equal
side
left
right
option
associ
lesion
periodont
diseas
gingiv
periodont
dental
resorpt
posit
fcv
rna
detect
realtim
rtpcr
scane
laboratori
toulous
franc
neg
felv
fiv
detect
snap
fivfelv
combo
test
idexx
previous
treat
least
month
prior
day
inclus
follow
conserv
periodont
treatment
scale
subgingiv
debrid
polish
extract
teeth
present
periodont
resorpt
lesion
teeth
surround
ulcer
ulceroprolif
caudal
stomat
andor
alveolarbucc
mucos
though
may
limit
teeth
cat
present
fcg
requir
extract
premolar
molar
teeth
clinic
radiograph
control
complet
tooth
extract
antibiot
treatment
pain
killer
antiinflammatori
drug
need
still
show
least
month
treatment
persist
clinic
sign
fcg
ulcer
ulceroprolif
caudal
stomat
alveolarbucc
mucos
associ
oral
discomfortpain
result
alter
food
intak
requir
medic
treatment
allow
proper
food
intak
day
inclus
note
product
b
everi
new
cat
meet
inclus
criteria
increment
case
number
attribut
correspond
envelop
contain
group
label
drawn
numer
order
group
anonym
maintain
throughout
studi
reveal
time
statist
analysi
perform
independ
statistician
twentyfour
cat
receiv
daili
administr
rfeifnu
virbagen
omega
virbac
carro
franc
mu
per
day
day
topic
oromucos
administr
rfeifnu
solut
reconstitut
mix
freezedri
pellet
diluent
suppli
manufactur
produc
muml
solut
three
insulin
syring
contain
ml
mu
reconstitut
ifn
solut
prepar
two
syring
frozen
solut
prepar
third
syring
dilut
ml
ifn
ml
steril
isoton
salin
dilut
aliquot
syring
ml
mu
one
syring
syring
administ
cat
syring
given
owner
store
fridg
c
pet
owner
administ
daili
one
syring
ml
dilut
ifn
solut
oromucos
administr
perform
posit
syring
caudal
canin
oral
commissur
cheek
solut
slowli
dispens
cheek
maintain
cat
mouth
close
min
maximis
mucos
contact
allow
slow
swallow
avoid
spill
solut
owner
came
back
clinic
occas
investig
defrost
frozen
insulin
syring
contain
ml
ifn
solut
prepar
fresh
dilut
normal
salin
aliquot
syring
describ
fifteen
cat
given
prednisolon
megasolon
merial
lyon
franc
oral
week
decreas
dose
rate
mgkgday
first
day
follow
mgkgday
everi
day
follow
day
follow
mg
kgday
everi
day
last
day
cat
includ
studi
receiv
week
antibiot
therapi
clindamycin
antirob
pfizer
mg
oral
solut
dose
mgkg
day
week
respect
blind
placebo
tablet
given
cat
ifn
group
use
protocol
describ
prednisolon
group
placebo
oral
administr
given
cat
prednisolon
group
use
protocol
describ
ifn
group
cours
studi
cat
present
acut
pain
oral
clinic
condit
requir
addit
therapi
rescu
medic
allow
treat
repeat
inject
butorphanol
alveges
virbac
dose
mgkg
sc
andor
daili
administr
meloxicam
metacam
boehring
ingelheim
oral
solut
mgml
dose
dropskg
less
day
andor
oral
administr
clindamycin
hydrochlorid
antirob
pfizer
dose
mgkgday
day
cat
observ
period
anim
examin
five
time
possibl
cat
condit
check
phone
call
visit
cat
bodi
weight
regist
follow
clinic
examin
perform
investig
efficaci
assess
behaviour
evalu
four
paramet
score
scale
inappet
pain
food
intak
yawn
hypersaliv
reduc
activ
sign
associ
fcg
assess
score
three
paramet
pain
open
cat
mouth
veterinarian
scale
halitosi
andor
thicken
saliva
scale
well
enlarg
mandibular
lymph
node
scale
paramet
score
normal
higher
score
synonym
worsen
condit
specif
inflammatori
lesion
fcg
evalu
score
three
paramet
caudal
stomat
intens
scale
alveolarbucc
mucos
scale
area
caudal
stomat
lesion
scale
score
system
use
efficaci
paramet
present
tabl
respons
treatment
classifi
worsen
lack
respons
moder
improv
mark
improv
complet
cure
well
gener
local
toler
treatment
assess
investig
owner
overal
treatment
complianc
also
evalu
owner
treatment
group
report
end
studi
whether
oral
administr
solut
easili
handl
efficaci
rfeifnu
primarili
assess
basi
progress
time
score
specif
inflammatori
lesion
lesion
area
paramet
consid
secondari
distribut
observ
continu
data
normal
nonparametr
wilcoxon
mann
whitney
test
use
treatment
group
comparison
time
point
pairwis
comparison
perform
within
treatment
group
everi
ontreat
time
point
use
nonparametr
sign
test
furthermor
effect
rescu
medic
mean
score
regist
paramet
studi
use
kruskalew
test
nonparametr
altern
oneway
anova
data
normal
distribut
test
allow
us
compar
treatment
group
median
score
cat
receiv
rescu
medic
median
score
cat
receiv
rescu
medic
categor
data
compar
treatment
group
use
c
test
fisher
exact
test
locf
last
observ
carri
forward
method
use
miss
data
last
observ
retain
next
record
threshold
signific
statist
analys
fix
bodi
weight
behaviour
fig
curv
mean
anim
bodi
weight
time
rel
flat
treatment
group
signific
intergroup
intragroup
differ
kg
ifn
group
versu
kg
prednisolon
group
progress
time
four
behaviour
paramet
show
overal
improv
lower
score
treatment
group
fig
mean
score
pain
food
intak
yawn
reduc
activ
significantli
improv
ifn
group
p
p
p
respect
compar
prednisolon
group
signific
intragroup
differ
also
shown
within
ifn
group
behaviour
paramet
inappet
p
time
point
pain
food
intak
yawn
p
hypersaliv
p
p
respect
reduc
activ
p
improv
decreas
score
prednisolon
group
notic
behaviour
paramet
except
hypersaliv
score
lower
p
tabl
score
system
use
evalu
lesion
caudal
stomat
intens
score
investig
score
intens
inflammatori
lesion
side
ie
right
left
separ
score
descript
absenc
lesion
slight
inflamm
ulcer
prolifer
spontan
bleed
bleed
induc
gentl
pressur
mild
inflamm
ulcer
slight
prolifer
spontan
bleed
bleed
induc
gentl
pressur
moder
inflamm
ulcer
ulceroprolif
lesion
may
observ
spontan
bleed
bleed
induc
gentl
pressur
lesion
sever
inflamm
ulcer
ulceroprolif
lesion
may
observ
spontan
bleed
alveolarbucc
mucos
score
score
descript
absenc
lesion
slight
inflamm
ulcer
prolifer
spontan
bleed
bleed
induc
gentl
pressur
mild
inflamm
ulcer
slight
prolifer
spontan
bleed
bleed
induc
gentl
pressur
moder
inflamm
ulcer
ulceroprolif
lesion
may
observ
spontan
bleed
bleed
induc
gentl
pressur
lesion
sever
inflamm
ulcer
ulceroprolif
lesion
may
observ
spontan
bleed
investig
score
area
inflammatori
lesion
side
ie
right
left
separ
score
descript
lesion
area
total
area
cm
total
area
cm
total
area
cm
total
area
cm
total
area
cm
total
area
cm
colour
templat
print
distribut
investig
order
better
evalu
surfac
area
sign
associ
fcg
syndrom
fig
overal
tendenc
improv
observ
treatment
group
mean
score
pain
open
cat
mouth
lower
ifn
group
p
p
respect
compar
prednisolon
group
fig
withingroup
differ
shown
pain
time
point
p
ifn
group
prednisolon
group
halitosi
decreas
p
ifn
group
p
prednisolon
group
mandibular
lymph
node
decreas
size
p
prednisolon
group
continu
steadi
decreas
score
observ
caudal
stomat
intens
area
caudal
stomat
treatment
group
alveolarbucc
mucos
ifn
group
fig
improv
signific
time
point
except
area
caudal
stomat
ifn
group
wherea
signific
area
caudal
stomat
prednisolon
group
tabl
howev
intergroup
differ
signific
three
score
analysi
made
combin
caudal
stomat
score
global
score
signific
decreas
lesion
score
time
point
compar
ifn
group
confirm
wherea
signific
decreas
prednisolon
group
observ
compar
repartit
five
categori
use
assess
respons
treatment
investig
owner
present
tabl
excel
correl
observ
investig
owner
evalu
complet
cure
mark
improv
occur
cat
ifn
group
cat
prednisolon
group
assess
made
investig
cat
ifn
group
cat
prednisolon
group
assess
made
owner
howev
differ
two
group
signific
eight
cat
ifn
group
versu
nine
cat
prednisolon
group
need
rescu
medic
cours
studi
differ
treatment
group
howev
signific
effect
rescu
medic
assess
compar
treatment
group
median
score
anim
receiv
rescu
medic
median
score
anim
receiv
rescu
medic
potenti
effect
rescu
medic
mean
score
reduc
activ
ifn
group
point
statist
differ
ifn
group
day
p
day
p
prednisolon
group
reduc
activ
score
median
score
anim
receiv
rescu
medic
median
score
anim
receiv
rescu
medic
signific
influenc
presenc
absenc
rescu
medic
score
pain
open
cat
mouth
time
treatment
group
influenc
ifn
group
regard
food
intak
pain
food
intak
yawn
time
point
hypersaliv
reduc
activ
prednisolon
group
also
signific
differ
rescu
medic
hypersaliv
withdraw
due
lack
efficaci
five
cat
ifn
group
versu
four
cat
prednisolon
group
withdrawn
studi
unsatisfactori
clinic
result
differ
treatment
group
signific
investig
opinion
treatment
well
toler
cat
ifn
group
versu
cat
prednisolon
group
two
advers
event
note
studi
one
treatment
group
one
case
dehydr
anorexia
ifn
group
one
case
polydipsia
prednisolon
group
treatment
stop
treatment
intoler
group
cat
receiv
oromucos
treatment
either
ifn
placebo
daili
day
well
tablet
either
prednisolon
placebo
daili
everi
day
day
owner
found
treatment
easi
administ
cat
ifn
group
cat
prednisolon
group
statist
differ
group
dental
extract
shown
provid
best
longterm
improv
cat
suffer
fcg
caudal
stomat
cat
clinic
cure
howev
cat
improv
treatment
still
requir
medic
order
eat
without
experienc
much
pain
apart
numer
anecdot
report
present
congress
publish
studi
treatment
cat
refractori
dental
extract
treatment
studi
first
randomis
control
doubleblind
studi
frustrat
condit
though
medic
treatment
recognis
gold
standard
condit
corticosteroid
use
posit
control
wide
frequent
use
practition
case
prednisolon
select
better
bioavail
toler
compar
prednison
dexamethason
taper
antiinflammatori
dose
chosen
order
lessen
adrenocort
suppress
avoid
stimul
viru
replic
chronic
viruscarri
young
old
cat
may
affect
condit
reflect
wide
rang
age
observ
studi
month
year
mean
age
cat
differ
group
vs
middleag
consist
cat
often
affect
earli
continu
suffer
long
period
time
also
consist
popul
previou
report
dental
treatment
cat
sex
predilect
cat
dsh
cat
due
low
preval
breed
studi
without
knowledg
breed
preval
differ
practic
involv
studi
breed
predilect
could
determin
individu
characterist
breed
sex
age
bodi
weight
fcg
histori
cat
treatment
group
significantli
differ
p
mean
bodi
weight
cat
within
normal
rang
popul
mainli
compos
dsh
cat
consist
mean
gener
condit
behaviour
score
inappet
pain
open
mouth
yawn
hypersaliv
reduc
activ
slightli
moder
alter
group
may
reflect
posit
effect
medic
given
cat
prior
inclus
studi
bodi
weight
maintain
throughout
studi
without
intragroup
intergroup
differ
deterior
gener
conditionbehaviour
score
notic
start
studi
previou
treatment
withdrawn
indic
group
treatment
abl
suffici
control
pain
enabl
cat
eat
import
point
human
reason
deal
debilit
condit
posit
control
group
use
one
ensur
cat
group
appropri
manag
ifn
group
pain
score
pain
food
intak
pain
cat
mouth
open
show
progress
signific
decreas
pain
along
time
reduc
activ
score
also
show
signific
decreas
activ
start
day
potenti
effect
rescu
medic
note
prevent
us
conclud
ifn
sole
respons
improv
activ
ifn
group
two
time
point
though
would
seem
logic
decreas
pain
would
result
activ
cat
pain
reduc
activ
score
also
decreas
prednisolon
group
subsequ
increas
howev
chang
signific
would
seem
logic
initi
cours
glucocorticoid
would
affect
paramet
howev
lack
signific
might
due
smaller
number
cat
prednisolon
group
compar
ifn
group
subsequ
lack
statist
power
hypersaliv
hand
show
progress
decreas
prednisolon
group
wherea
significantli
improv
ifn
group
mean
hypersaliv
score
statist
significantli
lower
p
prednisolon
group
statist
signific
influenc
rescu
medic
may
indic
though
prednisolon
stop
carryov
effect
may
observ
throughout
follow
studi
period
field
clinic
improv
usual
last
sever
day
glucocorticoid
treatment
stop
concern
favour
viral
activ
elect
give
cours
prednisolon
expect
possibl
carryov
effect
would
extend
improv
time
rescu
therapi
would
need
ifn
possess
direct
antiinflammatori
pain
kill
effect
expect
progress
modifi
immun
balanc
chronicallydiseas
cat
treatment
extend
whole
studi
period
compar
group
behaviour
paramet
clinic
sign
associ
fcg
mean
pain
score
food
intak
yawn
significantli
lower
less
pain
ifn
group
compar
prednisolon
group
p
mean
pain
score
open
cat
mouth
also
significantli
lower
less
pain
ifn
group
p
p
indic
though
ifn
possess
antiinflammatori
analges
effect
might
abl
trigger
suffici
improv
oral
caviti
condit
result
less
oral
pain
ifn
group
lesion
score
intens
surfac
area
caudal
stomat
well
intens
alveolarbucc
mucos
show
signific
decreas
p
time
except
surfac
area
p
comparison
signific
decreas
paramet
notic
cat
receiv
prednisolon
compar
group
togeth
signific
differ
observ
two
treatment
analysi
made
combin
caudal
stomat
score
global
score
intens
surfac
area
intens
surfac
area
signific
decreas
lesion
score
time
point
compar
ifn
group
confirm
wherea
signific
decreas
prednisolon
group
observ
compar
latter
might
due
direct
antiinflammatori
effect
first
week
howev
intergroup
differ
notic
either
appar
discrep
signific
improv
ifn
group
lack
signific
differ
prednisolon
group
togeth
lack
differ
two
treatment
regimen
might
due
low
number
cat
prednisolon
group
lack
statist
power
signific
decreas
time
lesion
score
cat
treat
ifn
clear
indic
effect
molecul
pathogen
process
lead
oral
inflammatori
lesion
cat
experienc
suffici
pain
studi
affect
abil
eat
allow
receiv
addit
nsaid
antibiot
rescu
medic
differ
group
might
also
mask
rescu
medic
given
cat
eight
cat
ifn
group
nine
cat
prednisolon
group
need
rescu
medic
cours
studi
differ
treatment
group
howev
signific
fisher
exact
test
p
thu
use
rescu
medic
unlik
affect
one
treatment
group
one
effect
rescu
medic
assess
detail
behaviour
score
score
like
modifi
addit
treatment
signific
influenc
rescu
medic
ifn
group
regard
pain
open
mouth
pain
food
intak
yawn
time
point
inappet
hypersaliv
reduc
activ
indic
signific
improv
pain
score
hypersaliv
score
group
like
due
treatment
effect
howev
statist
signific
differ
mean
reduc
activ
score
ifn
group
p
p
prednisolon
group
anim
receiv
rescu
medic
significantli
improv
mean
reduc
activ
score
ifn
group
p
p
might
due
rescu
medic
receiv
cat
pain
score
affect
rescu
medic
given
prednisolon
ifn
group
pain
relat
intens
extent
lesion
unlik
rescu
medic
could
significantli
affect
assess
lesion
score
overal
treatment
efficaci
assess
owner
investig
group
still
blind
good
statist
agreement
reach
clinician
owner
assess
treatment
efficaci
classifi
four
categori
total
effect
complet
clinic
cure
partial
effect
mark
moder
improv
ineffect
lack
improv
worsen
statist
differ
categori
ifn
prednisolon
group
clinic
cure
achiev
less
cat
whatev
treatment
surpris
consid
studi
popul
refractori
case
fcg
caudal
stomat
improv
dental
extract
medic
treatment
select
clinic
entiti
multifactori
condit
expect
treatment
would
magic
bullet
nevertheless
cat
ifn
group
prednisolon
group
either
clinic
cure
condit
moder
markedli
improv
studi
period
consid
cat
clinic
cure
markedli
improv
investig
found
cat
classifi
ifn
group
versu
prednisolon
group
though
result
encourag
ifn
group
statist
differ
group
like
due
low
number
cat
group
subsequ
lack
statist
power
studi
sever
limit
identifi
select
cat
follow
strict
inclusionexclus
criteria
studi
difficult
task
result
fewer
cat
incorpor
multicentr
studi
compar
origin
expect
like
result
lack
statist
power
might
account
lack
statist
signific
ifn
prednisolon
group
situat
statist
signific
improv
along
time
ifn
group
prednisolon
one
nevertheless
consid
strict
definit
condit
studi
strict
case
select
essenti
studi
fcg
mani
differ
clinic
condit
usual
mix
studi
panel
result
becom
imposs
interpret
studi
limit
time
might
month
long
enough
abl
show
improv
ifn
cat
seem
confirm
anecdot
report
clinic
experi
studi
felin
infecti
periton
fip
felin
leukaemia
viru
felv
felin
immunodefici
viru
fiv
surviv
time
gener
health
paramet
monitor
studi
period
much
longer
year
fcg
caudal
stomat
debilit
condit
fear
would
difficult
follow
cat
long
period
time
without
take
risk
lose
mani
cat
followup
andor
given
unauthoris
treatment
condit
need
adjunct
treatment
rescu
medic
expect
properli
plan
protocol
avoid
bia
studi
rescu
medic
may
artifici
improv
result
one
group
compar
one
might
case
reduc
activ
score
ifn
group
howev
influenc
differ
oral
pain
score
pain
food
intak
yawn
pain
investig
open
mouth
time
point
inappet
subsequ
improv
clinic
lesion
ifn
group
respons
treatment
group
bias
last
select
posit
control
cours
taper
prednisolon
treatment
instead
continu
administr
studi
period
though
latter
might
seen
better
option
sever
reason
decis
longterm
glucocorticoid
treatment
might
associ
variou
side
effect
especi
older
debilit
cat
well
chronic
oral
caliciviruscarri
field
glucocorticoid
often
administ
effect
taper
dose
week
carryov
effect
glucocorticoid
treatment
symptomat
resum
need
signific
decreas
hypersaliv
prednisolon
group
might
due
effect
conclus
daili
oromucos
administr
mu
rfeifnu
associ
signific
improv
clinic
lesion
caudal
stomat
alveolarbucc
mucos
decreas
pain
score
though
statist
improv
notic
prednisolon
group
howev
signific
differ
two
group
paramet
except
pain
within
limit
studi
oromucos
administr
rfeifnu
shown
result
signific
improv
found
least
good
shortterm
prednisolon
therapi
treatment
calicivirusposit
cat
present
fcg
caudal
stomat
refractori
dental
extract
studi
sponsor
virbac
sa
franc
